How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants
Recruiting now · Not applicable
Conditions studied: Respiratory Distress Syndrome (Neonatal), Respiratory Distress of Newborn
In brief
With this study, it is expected to learn more about preterm babies on breathing support with nasal continuous positive airway pressure (nCPAP). To gain more information on how much oxygen is actually delivered to the baby from the nCPAP machine.
Key facts
- Study ID
- NCT07674953
- Run by
- University of Arkansas
- People needed
- 10
- Starts
- 2026-04-15
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-06-30
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Gestational age at birth must be less than 35 weeks of completed gestation as documented in the subject's initial history and physical
- The infant must be stable while receiving nasal CPAP at any pressure level at the time of study
- The infant must be receiving 22-40% at the time of the study
You may not qualify if…
- Oxygen requirements greater than 40% at time of enrollment
- currently receiving invasive ventilation or not requiring ventilatory support
- Major congenital anomalies of the heart and/or lungs
Where it is running
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States (enrolling)
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.